コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 aire) and a lipoprotein subfraction profile (nuclear magnetic resonance spectroscopy).
2 ake rats as measured by ex vivo (1)H-[(13)C]-nuclear magnetic resonance spectroscopy.
3 y, and sequential (2)H and (31)P solid-state nuclear magnetic resonance spectroscopy.
4 c acids could not be detected in solution by nuclear magnetic resonance spectroscopy.
5 high-throughput mass spectrometry and proton nuclear magnetic resonance spectroscopy.
6 gated using solid-state magic angle spinning nuclear magnetic resonance spectroscopy.
7 specific ligand and loop interactions using nuclear magnetic resonance spectroscopy.
8 ference device magnetometry, and one (8+) by nuclear magnetic resonance spectroscopy.
9 Urine metabolic profiles were assessed using nuclear magnetic resonance spectroscopy.
10 using 2-aminopurine (2-AP) fluorescence and nuclear magnetic resonance spectroscopy.
11 ced by high resolution mass spectrometry and nuclear magnetic resonance spectroscopy.
12 ctly visualized by X-ray crystallography and nuclear magnetic resonance spectroscopy.
13 o protein tyrosine phosphatases (PTPs) using nuclear magnetic resonance spectroscopy.
14 (13)C heteronuclear single quantum coherence nuclear magnetic resonance spectroscopy.
15 rovirus (MNV), which have been determined by nuclear magnetic resonance spectroscopy.
16 quantified from serum samples by using (1)H nuclear magnetic resonance spectroscopy.
17 ation of a p53 based peptide was observed by nuclear magnetic resonance spectroscopy.
18 Serum metabolome was quantified by nuclear magnetic resonance spectroscopy.
19 19, was shown to be L-fucono-1,5-lactone via nuclear magnetic resonance spectroscopy.
20 Circulating amino acids were assessed by nuclear magnetic resonance spectroscopy.
21 in an extended conformation as determined by nuclear magnetic resonance spectroscopy.
22 eight amino acids were measured with proton nuclear magnetic resonance spectroscopy.
23 isible spectrometry, gas chromatography, and nuclear magnetic resonance spectroscopy.
24 nd total fatty acids were analyzed by proton nuclear magnetic resonance spectroscopy.
25 Co(III)-H complex that was characterized by nuclear magnetic resonance spectroscopy.
26 ass spectrometry, Western blot analysis, and nuclear magnetic resonance spectroscopy.
27 ors by X-ray crystallography, Mossbauer, and nuclear magnetic resonance spectroscopy.
28 um-239 ((239)Pu) nucleus should be active in nuclear magnetic resonance spectroscopy.
29 using a combination of mass spectrometry and nuclear magnetic resonance spectroscopy.
30 sform mass spectrometry, and two-dimensional nuclear magnetic resonance spectroscopy.
31 e characterized by imino proton exchange and nuclear magnetic resonance spectroscopy.
32 y ZT0715, purified samples were analyzed via nuclear magnetic resonance spectroscopy.
33 ticle number and size were measured by using nuclear magnetic resonance spectroscopy.
34 otein concentration and diameter obtained by nuclear magnetic resonance spectroscopy.
35 rationalized our findings with modeling and nuclear magnetic resonance spectroscopy.
36 plasmic space, are characterized by solution nuclear magnetic resonance spectroscopy.
37 um two-dimensional Fourier transform (2D FT) nuclear magnetic resonance spectroscopy.
38 have implications for the utility of in-cell nuclear magnetic resonance spectroscopy.
39 ized by isothermal titration calorimetry and nuclear magnetic resonance spectroscopy.
40 ine apo-Mts1 homodimer have been examined by nuclear magnetic resonance spectroscopy.
41 gs to human bone using 2H, 13C, 15N, and 31P nuclear magnetic resonance spectroscopy.
42 r lipoprotein particle number and size using nuclear magnetic resonance spectroscopy.
43 ometry, electron paramagnetic resonance, and nuclear magnetic resonance spectroscopy.
44 iameters and concentrations were measured by nuclear magnetic resonance spectroscopy.
45 ere assessed with the use of high-throughput nuclear magnetic resonance spectroscopy.
46 n time-of-flight mass spectrometry and (31)P nuclear magnetic resonance spectroscopy.
47 vable at ambient temperature by conventional nuclear magnetic resonance spectroscopy.
48 romatography-tandem mass spectrometry and/or nuclear magnetic resonance spectroscopy.
49 pectrometry and lipidome analysis using (1)H nuclear magnetic resonance spectroscopy.
50 ve basic determinants that are identified by nuclear magnetic resonance spectroscopy.
51 s spectrometry, tandem mass spectrometry and nuclear magnetic resonance spectroscopy.
52 determined using (1)H and (7)Li solid-state nuclear magnetic resonance spectroscopy.
53 We measured GlycA by nuclear magnetic resonance spectroscopy.
54 se diagrams, vibrational spectroscopies, and nuclear magnetic resonance spectroscopy.
55 perties in vitro and on protein structure by Nuclear Magnetic Resonance spectroscopy.
56 anitidine measured by quantitative deuterium nuclear magnetic resonance spectroscopy.
57 by gas chromatography-mass spectrometry and nuclear magnetic resonance spectroscopy.
58 nt centers were observed through solid-state nuclear magnetic resonance spectroscopy.
59 of blood plasma was undertaken using proton nuclear magnetic resonance spectroscopy.
60 t 3.5 A resolution, which is validated using nuclear magnetic resonance spectroscopy.
61 r QD nucleation using optical absorption and nuclear magnetic resonance spectroscopies.
62 -Cu (10 and 20 mg/L) was evaluated by proton nuclear magnetic resonance spectroscopy ((1)H NMR) and g
67 y electrospray ionization mass spectrometry, nuclear magnetic resonance spectroscopy ((27)Al liquid-s
68 ty of two-dimensional diffusion-ordered (1)H nuclear magnetic resonance spectroscopy (2D DOSY (1)H NM
69 hod for the identification of InsP(n), (31)P nuclear magnetic resonance spectroscopy ((31)P NMR).
70 althy and IPF lung tissue were determined by nuclear magnetic resonance spectroscopy; alpha-smooth mu
71 orimetry and changes in chemical shifts from nuclear magnetic resonance spectroscopy also support the
72 ith immunoassay, and LDL-P was measured with nuclear magnetic resonance spectroscopy among 27 533 hea
75 age- and sex-matched healthy controls, using nuclear magnetic resonance spectroscopy and a validated
76 HDL particle concentrations were measured by nuclear magnetic resonance spectroscopy and categorized
78 7 at the level of individual residues using nuclear magnetic resonance spectroscopy and compare thes
79 structural elucidation has relied heavily on nuclear magnetic resonance spectroscopy and computationa
80 involvement with the X-ray crystallography, Nuclear Magnetic Resonance spectroscopy and cryo-Electro
82 using (31)P solid-state magic-angle-spinning nuclear magnetic resonance spectroscopy and differential
84 ction was combined, for the first time, with Nuclear Magnetic Resonance spectroscopy and direct infus
85 -palmitate or (13)C-oleate for dynamic (13)C nuclear magnetic resonance spectroscopy and end point li
86 s involving two controlled vocabularies (for nuclear magnetic resonance spectroscopy and gas chromato
90 t the use of low-temperature rapid injection nuclear magnetic resonance spectroscopy and kinetic stud
94 (designated Mma_DMAG) using a combination of nuclear magnetic resonance spectroscopy and mass spectro
95 c products, which were characterized by (1)H nuclear magnetic resonance spectroscopy and mass spectro
97 y studies, Isothermal Titration Calorimetry, Nuclear Magnetic Resonance spectroscopy and molecular mo
99 complex with the nucleosome, using solution nuclear magnetic resonance spectroscopy and other biophy
100 erefore, saturation transfer difference [1H]-nuclear magnetic resonance spectroscopy and protein-drug
102 We have characterized the interaction by nuclear magnetic resonance spectroscopy and show that it
103 n splicing factor U2AF65 using complementary nuclear magnetic resonance spectroscopy and small-angle
104 he inflorescence cell wall using solid-state nuclear magnetic resonance spectroscopy and small-angle
105 st that metabolic changes detected by proton nuclear magnetic resonance spectroscopy and the bioinfor
107 te extracts were analysed using 600 MHz (1)H Nuclear Magnetic Resonance spectroscopy and Ultra-Perfor
108 nanoparticles formation is elucidated using nuclear magnetic resonance spectroscopy and with molecul
111 re was characterized using proton and carbon nuclear magnetic resonance spectroscopies, and infrared
112 acetone (DHA) in D(2)O was monitored by (1)H nuclear magnetic resonance spectroscopy, and a k(cat)/K(
113 cle concentrations and size were measured by nuclear magnetic resonance spectroscopy, and apolipoprot
114 by hyperpolarized in vivo pyruvate studies, nuclear magnetic resonance spectroscopy, and carbon-13 f
116 tion mutagenesis, surface plasmon resonance, nuclear magnetic resonance spectroscopy, and cross-linki
117 Here we use biochemistry, mass spectrometry, nuclear magnetic resonance spectroscopy, and genetic ana
118 UPITER), HDL size and HDL-P were measured by nuclear magnetic resonance spectroscopy, and HDL-C and a
119 etic field, solid-state magic-angle spinning nuclear magnetic resonance spectroscopy, and high-angle
120 xamined using pyruvate tolerance tests, (2)H nuclear magnetic resonance spectroscopy, and in vitro HG
121 y bioluminescence resonance energy transfer, nuclear magnetic resonance spectroscopy, and isothermal
122 AS proteins using microscale thermophoresis, nuclear magnetic resonance spectroscopy, and isothermal
123 f conventional photophysical investigations, nuclear magnetic resonance spectroscopy, and kinetic stu
124 ared and Raman spectroscopy, (15)N and (31)P nuclear magnetic resonance spectroscopy, and mass spectr
125 Here, using vibrational and solid-state nuclear magnetic resonance spectroscopy, and molecular d
126 relation spectroscopy, optical spectroscopy, nuclear magnetic resonance spectroscopy, and nitrogen so
127 hanced Raman spectroscopy, (27)Al and (35)Cl nuclear magnetic resonance spectroscopy, and pair distri
130 Here we have tested the potentiality of nuclear magnetic resonance spectroscopy as "magnetic ton
131 e was elucidated using mass spectrometry and nuclear magnetic resonance spectroscopy as 2-heptyl-2-hy
132 This pilot study evaluated plasma proton nuclear magnetic resonance spectroscopy as a means to mo
133 now been identified by mass spectrometry and nuclear magnetic resonance spectroscopy as monoglucosyl
134 d in connection with chemical shifts of (1)H nuclear magnetic resonance spectroscopy, as they can exh
137 that includes small angle x-ray scattering, nuclear magnetic resonance spectroscopy, circular dichro
138 tion mixture using gas chromatography-MS and nuclear magnetic resonance spectroscopy confirms the for
140 orbate in the aqueous humor was evaluated by nuclear magnetic resonance spectroscopy; crystalline len
141 simulated data and has been applied to real nuclear magnetic resonance spectroscopy data collected i
142 wo tetrareduced corannulene decks, and (7)Li nuclear magnetic resonance spectroscopy delineates a con
147 ion of the compound's solution properties by nuclear magnetic resonance spectroscopy, density functio
148 imates of LDL-P and size can also be made by nuclear magnetic resonance spectroscopy, density gradien
149 etic subjects (HbA1c 6.5 +/- 0.2%) using 13C nuclear magnetic resonance spectroscopy, during 2 h of e
150 ding dsRNA-dependent activation of PKR using nuclear magnetic resonance spectroscopy, dynamic light s
151 -averaged structural restraints derived from nuclear magnetic resonance spectroscopy enables the dete
152 Rh=C bond, characterized by vibrational and nuclear magnetic resonance spectroscopy, extended x-ray
153 tion, levels at which circular dichroism and nuclear magnetic resonance spectroscopy fingerprinting,
154 netic relaxation enhancement measurements by nuclear magnetic resonance spectroscopy, from which long
155 influenced by Nox1 deletion as determined by nuclear magnetic resonance spectroscopy, glucose toleran
156 on mass spectrometry, linkage analysis, (1)H nuclear magnetic resonance spectroscopy, glycan inhibiti
159 quantitative metabolomics platform based on nuclear magnetic resonance spectroscopy has found widesp
161 ichroism, steady-state Trp fluorescence, and nuclear magnetic resonance spectroscopy have shown previ
162 videnced by a unique combination of solution nuclear magnetic resonance spectroscopy, high molecular
163 ion mass spectrometry-solid-phase extraction-nuclear magnetic resonance spectroscopy (HR-bioassay/HPL
165 liquid chromatography-solid-phase extraction-nuclear magnetic resonance spectroscopy, i.e., HPLC-SPE-
166 y, solid-phase extraction, and tube-transfer nuclear magnetic resonance spectroscopy, i.e., HPLC-SPE-
169 olyacrylamide gel electrophoresis (PAGE) and nuclear magnetic resonance spectroscopy in addition to I
170 e (up to 2 gigapascals) boron-11 solid-state nuclear magnetic resonance spectroscopy in combination w
171 ESEARCH DESIGN AND We utilized in vivo (13)C nuclear magnetic resonance spectroscopy in conjunction w
172 plementation of pulsed electrically detected nuclear magnetic resonance spectroscopy in organic light
173 our current discussion highlights the use of nuclear magnetic resonance spectroscopy in the drug disc
174 ng metabolites quantified by high-throughput nuclear magnetic resonance spectroscopy in two populatio
175 s were measured using (2)H/(13)C tracers and nuclear magnetic resonance spectroscopy in ZDF rats duri
176 nto transient HG bps, we used solution-state nuclear magnetic resonance spectroscopy, including measu
177 mass spectrometry, along with (1)H and (13)C nuclear magnetic resonance spectroscopy, including two-d
178 n itself at the junction of BR and GPA1, and nuclear magnetic resonance spectroscopy indicated that t
179 -coordinate complexes in the solid state, 1H nuclear magnetic resonance spectroscopy indicates that t
180 visible absorption spectroscopy, solid-state nuclear magnetic resonance spectroscopy, infrared spectr
185 ucture of these species was characterized by nuclear magnetic resonance spectroscopy, mass spectromet
187 lues, we evaluated associations of HDL-C and nuclear magnetic resonance spectroscopy-measured HDL-P w
188 el using quantitative high-resolution proton nuclear magnetic resonance spectroscopy metabolomics.
190 on of methyl-transverse relaxation optimized nuclear magnetic resonance spectroscopy (methyl-TROSY) a
193 ts, including a compound later identified by nuclear magnetic resonance spectroscopy (NMR) as "dekete
196 uided SPE-trapping of selected compounds for nuclear magnetic resonance spectroscopy (NMR) measuremen
197 lated Tau by activated recombinant ERK2 with nuclear magnetic resonance spectroscopy (NMR) reveals ph
198 ysis (TGA), infrared spectroscopy (FTIR) and nuclear magnetic resonance spectroscopy (NMR) were also
201 change tandem mass spectrometry (H/D-MS/MS), nuclear magnetic resonance spectroscopy (NMR), cross-lin
202 he resulting oligomers were characterized by nuclear magnetic resonance spectroscopy (NMR), cyclic vo
203 rence fatty acid methyl esters (FAMEs), (1)H nuclear magnetic resonance spectroscopy (NMR), employing
207 mpositional analysis, mass spectrometry, and nuclear magnetic resonance spectroscopy of a purified ML
209 106 candidate biomarkers were quantified by nuclear magnetic resonance spectroscopy of non-fasting p
210 ile of acute myocardial ischemia (MIS) using nuclear magnetic resonance spectroscopy of peripheral bl
212 ong spectral shifts are observed by solution nuclear magnetic resonance spectroscopy of specific N-te
213 port the design and structural validation by nuclear magnetic resonance spectroscopy of the first sta
215 ein has proven resistant to crystallization, nuclear magnetic resonance spectroscopy offers a unique
216 Using methyl transverse relaxation-optimized nuclear magnetic resonance spectroscopy on a 450-kilodal
218 aptamer domain of an adenine riboswitch for nuclear magnetic resonance spectroscopy or single-molecu
220 n were demonstrated by mass spectrometry and nuclear magnetic resonance spectroscopy, respectively.
223 rahigh-resolution mass spectrometry (MS) and nuclear magnetic resonance spectroscopy reveal abundant
224 corporation to wood over a time course using nuclear magnetic resonance spectroscopy revealed diurnal
230 sing a combination of X-ray crystallography, nuclear magnetic resonance spectroscopy, SAXS and molecu
231 nts using Langendorff preparations and (13)C nuclear magnetic resonance spectroscopy showed a 36% dec
232 ns (IDPs) and of denatured proteins based on nuclear magnetic resonance spectroscopy, small-angle X-r
240 erification of mass spectrometric data using nuclear magnetic resonance spectroscopy, this comprehens
243 ntly introduced multidimensional solid-state nuclear magnetic resonance spectroscopy to characterize
244 ived from (2)H, (13)C, and (31)P solid-state nuclear magnetic resonance spectroscopy to decipher the
245 ated using solubility enhancement as well as nuclear magnetic resonance spectroscopy to demonstrate s
246 learn about VSD-lipid interactions, we used nuclear magnetic resonance spectroscopy to determine the
255 ermine the impact of this dichotomy, we used nuclear magnetic resonance spectroscopy to measure the b
258 inity capture and use it in combination with nuclear magnetic resonance spectroscopy to show preferen
259 on cyclotron resonance mass spectrometry and nuclear magnetic resonance spectroscopy to show that a s
262 namic nuclear polarization-based solid-state nuclear magnetic resonance spectroscopy to validate a st
263 on the innovative application of (13)C NMR (nuclear magnetic resonance) spectroscopy to determine th
264 efrontal cortex was measured by (1)H-[(13)C]-nuclear magnetic resonance spectroscopy together with in
265 using calibrated (19)F magic angle spinning nuclear magnetic resonance spectroscopy upon exposure to
266 metabolic content measured in lymphocytes by nuclear magnetic resonance spectroscopy was altered in s
274 mations of Escherichia coli H69 in solution, nuclear magnetic resonance spectroscopy was used to reve
276 AS-NMR (High Resolution Magic Angle Spinning Nuclear Magnetic Resonance) spectroscopy was applied her
278 g a combination of x-ray crystallography and nuclear magnetic resonance spectroscopy, we carry out a
280 cludes differential scanning calorimetry and nuclear magnetic resonance spectroscopy, we demonstrate
285 involving proteins and methylated targets by nuclear magnetic resonance spectroscopy, we devised a si
288 ctional theory calculations, and solid-state nuclear magnetic resonance spectroscopy, we have refined
291 tron scattering methods with vibrational and nuclear magnetic resonance spectroscopy, we show that ce
293 X) in conjunction with mass spectrometry and nuclear magnetic resonance spectroscopy were used for th
295 -resolution mass spectrometry (HRMS(n)), and nuclear magnetic resonance spectroscopy, which enabled t
296 The IgE and IgA paratopes were probed by nuclear magnetic resonance spectroscopy with (15)N-label
298 ycles by (7)Li, (19)F, and (13)C solid-state nuclear magnetic resonance spectroscopies, with the orga
299 X-ray crystallographic studies, multi-nuclei nuclear magnetic resonance spectroscopy, X-ray absorptio
300 length scale--including magic angle spinning nuclear magnetic resonance spectroscopy, X-ray fiber dif
WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。